122 related articles for article (PubMed ID: 9259964)
1. Carcinoma of the male breast: analysis of prognosis compared with matched female patients.
Borgen PI; Senie RT; McKinnon WM; Rosen PP
Ann Surg Oncol; 1997; 4(5):385-8. PubMed ID: 9259964
[TBL] [Abstract][Full Text] [Related]
2. [Breast carcinoma in the man. Current results from the viewpoint of clinic and pathology].
Prechtel K; Prechtel V
Pathologe; 1997 Jan; 18(1):45-52. PubMed ID: 9157404
[TBL] [Abstract][Full Text] [Related]
3. Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients.
Li X; Yang J; Krishnamurti U; Huo L; Ward KC; O'Regan R; Peng L
Clin Breast Cancer; 2017 Aug; 17(5):356-366. PubMed ID: 28576631
[TBL] [Abstract][Full Text] [Related]
4. Men and women show similar survival outcome in stage IV breast cancer.
Wu SG; Zhang WW; Liao XL; Sun JY; Li FY; Su JJ; He ZY
Breast; 2017 Aug; 34():115-121. PubMed ID: 28577471
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
[TBL] [Abstract][Full Text] [Related]
6. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome.
Joshi MG; Lee AK; Loda M; Camus MG; Pedersen C; Heatley GJ; Hughes KS
Cancer; 1996 Feb; 77(3):490-8. PubMed ID: 8630956
[TBL] [Abstract][Full Text] [Related]
7. Occult breast carcinoma presenting with axillary lymph node metastases: a follow-up study of 48 patients.
Rosen PP; Kimmel M
Hum Pathol; 1990 May; 21(5):518-23. PubMed ID: 2338331
[TBL] [Abstract][Full Text] [Related]
8. Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study.
Wei JL; Zhang JX; Fu DY
World J Surg Oncol; 2018 Dec; 16(1):236. PubMed ID: 30558615
[TBL] [Abstract][Full Text] [Related]
9. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients].
Aftimos G; Trak-Smayra V; Moacdieh-Rehayel L
J Med Liban; 2000; 48(1):8-17. PubMed ID: 10881437
[TBL] [Abstract][Full Text] [Related]
10. Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.
Fisher B; Dignam J; Tan-Chiu E; Anderson S; Fisher ER; Wittliff JL; Wolmark N
J Natl Cancer Inst; 2001 Jan; 93(2):112-20. PubMed ID: 11208880
[TBL] [Abstract][Full Text] [Related]
11. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
12. Alterations in hormonal receptor expression and HER2 status between primary breast tumors and paired nodal metastases: discordance rates and prognosis.
Ba JL; Liu CG; Jin F
Asian Pac J Cancer Prev; 2014; 15(21):9233-9. PubMed ID: 25422206
[TBL] [Abstract][Full Text] [Related]
13. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases.
Wang-Rodriguez J; Cross K; Gallagher S; Djahanban M; Armstrong JM; Wiedner N; Shapiro DH
Mod Pathol; 2002 Aug; 15(8):853-61. PubMed ID: 12181271
[TBL] [Abstract][Full Text] [Related]
14. GATA-3 expression in male and female breast cancers: comparison of clinicopathologic parameters and prognostic relevance.
Gonzalez RS; Wang J; Kraus T; Sullivan H; Adams AL; Cohen C
Hum Pathol; 2013 Jun; 44(6):1065-70. PubMed ID: 23266442
[TBL] [Abstract][Full Text] [Related]
15. Chinese female breast cancer patients show a better overall survival than their male counterparts.
Xia LP; Zhou FF; Guo GF; Wang F; Wang X; Yuan ZY; Zhang B
Chin Med J (Engl); 2010 Sep; 123(17):2347-52. PubMed ID: 21034547
[TBL] [Abstract][Full Text] [Related]
16. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients.
Aryandono T; Harijadi ; Ghozali A
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217
[TBL] [Abstract][Full Text] [Related]
17. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
Barth A; Craig PH; Silverstein MJ
Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
[TBL] [Abstract][Full Text] [Related]
18. [Male breast cancer: prognostic factors, diagnosis and treatment: a multi-institutional survey of 95 cases].
Oger AS; Boukerrou M; Cutuli B; Campion L; Rousseau E; Bussières E; Raro P; Classe JM
Gynecol Obstet Fertil; 2015 Apr; 43(4):290-6. PubMed ID: 25818033
[TBL] [Abstract][Full Text] [Related]
19. Poorer survival of male breast cancer compared with female breast cancer patients may be due to biological differences.
Chen X; Liu X; Zhang L; Li S; Shi Y; Tong Z
Jpn J Clin Oncol; 2013 Oct; 43(10):954-63. PubMed ID: 23935206
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
